Q: How about biologics? Are there concerns with using them in IBD? Pyrsopoulos: Biologics are often used to treat moderate-to-severe disease states in IBD.

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

The European Union has banned a key ingredient found in many gel nail polishes, effective Monday, Sept. 1. The ingredient, ...

A substantial number of patients with inflammatory bowel disease rely on cannabis and CBD oil for symptom relief, indicating a need for more rigorous investigation, according to a study published in ...

SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed.

About 3 million Americans are living with the pain of inflammatory bowel disease.

The marketplace introduction of infliximab for the treatment of IBD did not reduce hospitalization or surgery rates in a large population of patients with Crohn disease and ulcerative colitis.